Generic drugmaker Teva recently pulled out of settlement talks with the Justice Department. The company is “betting that in the middle of a deadly pandemic, the Trump administration won’t
dare to come down hard on the largest supplier of generic drugs in the United States,” per The New York Times
. President Trump had been touting an anti-malaria drug, hydroxychloroquine,
as a possible “game changer’” in the fight against the coronavirus. Teva made hydroxychloroquine overseas and could export it to the United States. Trump announced
he has been taking the drug to lessen symptoms should he get the coronavirus, even though it is unproven for fighting COVID-19.
Read the whole story at The New York Times »